Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nebulized Dexmedetomidine for PDPH
NCT06470854Completed
- Sponsor
- Tanta University
- Start
- Nov 2023
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of dexmedetomidine in post-dural puncture headache (PDPH) (2 arms), sponsored by Tanta University. Primary endpoint: The extent of reduction of consumed analgesia at 5 months. Started Nov 2023; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT06470854.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06470854.